---
figid: PMC4369651__fphar-06-00052-g001
figlink: /pmc/articles/PMC4369651/figure/F1/
number: F1
caption: 'Methotrexate pathway. Methotrexate and its active polyglutamate metabolites
  interfere with several intracellular metabolic processes in particular one-carbon
  metabolism and de novo purine and pyrimidine synthesis, by inhibiting the activity
  of key enzymes such as DHFR, ATIC, and TYMS. This antimetabolic effect may lead
  to alteration in intracellular nucleotide pools and increased adenosine release,
  determining the anti-rheumatic effect of methotrexate. ABCs, ATP-binding cassette
  transporters; AMP, adenosine monophosphate; ATIC, adenosine ribonucleotide transformylase;
  DHFR, dihydrofolate reductase; FPGS, folylpolyglutamate synthase; GGH, gamma-glutamyl
  hydrolase; IMP, inosine monophosphate; ITP: inosine triphosphate; ITPA, inosine
  triphosphate-pyrophosphatase; SLC19A1, solute carrier family 19 member 1; TYMS,
  thymidylate synthetase.'
pmcid: PMC4369651
papertitle: Genetic determinants for methotrexate response in juvenile idiopathic
  arthritis.
reftext: Serena Pastore, et al. Front Pharmacol. 2015;6:52.
pmc_ranked_result_index: '16837'
pathway_score: 0.831771
filename: fphar-06-00052-g001.jpg
figtitle: Methotrexate pathway
year: '2015'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4369651__fphar-06-00052-g001.html
  '@type': Dataset
  description: 'Methotrexate pathway. Methotrexate and its active polyglutamate metabolites
    interfere with several intracellular metabolic processes in particular one-carbon
    metabolism and de novo purine and pyrimidine synthesis, by inhibiting the activity
    of key enzymes such as DHFR, ATIC, and TYMS. This antimetabolic effect may lead
    to alteration in intracellular nucleotide pools and increased adenosine release,
    determining the anti-rheumatic effect of methotrexate. ABCs, ATP-binding cassette
    transporters; AMP, adenosine monophosphate; ATIC, adenosine ribonucleotide transformylase;
    DHFR, dihydrofolate reductase; FPGS, folylpolyglutamate synthase; GGH, gamma-glutamyl
    hydrolase; IMP, inosine monophosphate; ITP: inosine triphosphate; ITPA, inosine
    triphosphate-pyrophosphatase; SLC19A1, solute carrier family 19 member 1; TYMS,
    thymidylate synthetase.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SLC19A1
  - FPGS
  - BRAP
  - DHFR
  - MFAP1
  - ITPA
  - ATIC
  - GGH
  - TYMS
  - pyrimidine
  - Adenosine
  - ITP
  - Methotrexate
  - purine
genes:
- word: SLC19A1
  symbol: SLC19A1
  source: hgnc_symbol
  hgnc_symbol: SLC19A1
  entrez: '6573'
- word: FPGS
  symbol: FPGS
  source: hgnc_symbol
  hgnc_symbol: FPGS
  entrez: '2356'
- word: IMP
  symbol: IMP
  source: hgnc_alias_symbol
  hgnc_symbol: BRAP
  entrez: '8315'
- word: DHFR
  symbol: DHFR
  source: hgnc_symbol
  hgnc_symbol: DHFR
  entrez: '1719'
- word: AMP
  symbol: AMP
  source: hgnc_alias_symbol
  hgnc_symbol: MFAP1
  entrez: '4236'
- word: ITPA
  symbol: ITPA
  source: hgnc_symbol
  hgnc_symbol: ITPA
  entrez: '3704'
- word: ATIC
  symbol: ATIC
  source: hgnc_symbol
  hgnc_symbol: ATIC
  entrez: '471'
- word: GGH
  symbol: GGH
  source: hgnc_symbol
  hgnc_symbol: GGH
  entrez: '8836'
- word: TYMS
  symbol: TYMS
  source: hgnc_symbol
  hgnc_symbol: TYMS
  entrez: '7298'
chemicals:
- word: pyrimidine
  source: MESH
  identifier: C030986
- word: Adenosine
  source: MESH
  identifier: D000241
- word: ITP
  source: MESH
  identifier: D007293
- word: Methotrexate
  source: MESH
  identifier: D008727
- word: purine
  source: MESH
  identifier: D011687
diseases: []
figid_alias: PMC4369651__F1
redirect_from: /figures/PMC4369651__F1
figtype: Figure
---
